Memorializing Governor Kathy Hochul to proclaim May 2026, as Amyotrophic Lateral Sclerosis Awareness Month in the State of New York
Summary
This resolution memorializes Governor Kathy Hochul to proclaim May 2026 as Amyotrophic Lateral Sclerosis (ALS) Awareness Month in New York State. It is a ceremonial measure that does not create a new program, mandate, or funding stream; instead, it expresses the Legislature’s support for public awareness of ALS and its effects on patients and families.
The resolution includes background on ALS, also known as Lou Gehrig’s disease, describing it as a progressive and ultimately fatal neurodegenerative disease that impairs voluntary movement, speech, swallowing, and breathing. It notes that ALS can be sporadic or familial, affects thousands of Americans each year, and disproportionately impacts adults over 60 and military veterans. The stated purpose is to encourage greater awareness at the local, state, and national levels and to recognize the burden of the disease on those living with it and their caregivers.
Impact
Because this is a Senate resolution memorializing the Governor, it does not amend the Public Health Law or any other statute, and it does not impose legal obligations on agencies, health providers, or the public. Its practical effect is limited to officially designating May 2026 as ALS Awareness Month if the Governor issues the proclamation, thereby supporting awareness campaigns, advocacy, and public education efforts related to ALS.
Sentiment
The overall sentiment is strongly supportive and noncontroversial. The resolution uses solemn, sympathetic language and frames ALS as a serious health condition deserving of heightened public attention. No votes, committee transcripts, or recorded opposition are provided, suggesting the measure was presented as a consensus awareness resolution rather than a contested policy proposal.
Contention
There are no documented points of contention in the available record. Because the measure is a commemorative resolution, any disagreement would likely be limited to the general question of whether legislative time should be devoted to proclamations rather than substantive policy, but no such criticism appears in the bill materials or voting history. The resolution is focused on recognition and awareness, not on treatment access, funding, or regulatory changes.